AMEX: BTX       Brooklyn Immunotherapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
0.00   0.00 (0.00%)  0.00 - 0.00  0


Avg Volume (4 weeks):0
52 Weeks Range:0.22 - 0.78
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

BioTime Inc is a clinical-stage biotechnology company. Its objective is the development and commercialization of novel therapies developed with the help of the company's core technology platforms. The core therapeutic technologies are based on pluripotent stem cells that can become any of the cell types in the human body. Pluripotent stem cells have potential applications in many areas of medicine, including several age-related degenerative diseases and conditions for which there presently are no cures. The product portfolio includes Renevia, a potential treatment for HIV-related facial lipoatrophy; AST-VAC1, a cancer immunotherapy; and OpRegen, a potential therapy derived from pluripotent stem cells to treat the dry form of age-related macular degeneration.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

6687  2946  917  902 

Top 10 Active Counters
 TSLA 213.97+6.45 
 SQQQ 21.74-0.48 
 TQQQ 36.82+0.81 
 T 15.21-0.60 
 UTRS 0.293+0.093 
 MMV 2.04+1.09 
 SPY 427.92+6.10 
 YJ 0.32+0.108 
 PLTR 14.52-0.02 
 BAC 28.71+0.93